Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Nilsson, , Khalid,
DOB:	10-APR-1952 (Age: 73)
Gender:	male
Address:	Gengränd 482 691 31 Karlskoga (Sweden)
ID:	8339-594203-6 (ECI)

Report
Date:	20-SEP-2022

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Karlskoga Lasarett 691 31 Karlskoga (Sweden)

Specimen
Collected:	19-SEP-2022

Chemistry

Test	20-SEP-2022	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	6.2	4.5 - 6.4	%
Glucose [Mass/volume] in Blood	97.9	70 - 99	mg/dL
Urea nitrogen [Mass/volume] in Blood	10.8	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	0.8 L	0.9 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	9.4	8.6 - 10.2	mg/dL
Sodium [Moles/volume] in Blood	141.3	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.7	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	102.0	98 - 108	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	28.4	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	144.8	0 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	122.9	40 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	80.1	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	40.2	40 - 100	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All measured parameters are within or close to normal ranges. HbA1c is at the upper limit, suggesting good but borderline glycemic control. Creatinine is slightly below normal but not clinically significant. Lipid profile is favorable, with LDL and triglycerides well controlled and HDL at the lower normal limit. No acute abnormalities detected. Recommend continued monitoring, especially of glycemic control.

Conclusion and Recommendations based on this report and previous findings known to us

All measured parameters are within or close to normal ranges. HbA1c is at the upper limit, suggesting good but borderline glycemic control. Creatinine is slightly below normal but not clinically significant. Lipid profile is favorable, with LDL and triglycerides well controlled and HDL at the lower normal limit. No acute abnormalities detected. Recommend continued monitoring, especially of glycemic control.